Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Brecsurf and Curosurf on Respiratory Distress in Newborns
IRCT20250222064805N1Phase 2Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Feb 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of Poractant alfa in respiratory distress syndrome (RDS) (2 arms), sponsored by Ardabil University of Medical Sciences. Started Feb 2025; status: completed.
02
Drugs
Poractant alfa
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT20250222064805N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250222064805N1.